ValuEngine downgraded shares of Nu Skin Enterprises (NYSE:NUS) from a buy rating to a hold rating in a research report sent to investors on Friday morning.
A number of other research analysts have also issued reports on NUS. Zacks Investment Research upgraded Nu Skin Enterprises from a sell rating to a hold rating in a research report on Monday, October 15th. Jefferies Financial Group restated a buy rating and issued a $92.00 price objective on shares of Nu Skin Enterprises in a report on Thursday, November 8th. Citigroup set a $88.00 price objective on Nu Skin Enterprises and gave the company a buy rating in a report on Thursday, November 8th. Tigress Financial restated a buy rating on shares of Nu Skin Enterprises in a report on Wednesday, November 21st. Finally, Bank of America restated an underperform rating and issued a $65.00 price objective (down previously from $75.00) on shares of Nu Skin Enterprises in a report on Thursday, December 6th. Two research analysts have rated the stock with a sell rating, three have issued a hold rating and five have assigned a buy rating to the company. The stock currently has an average rating of Hold and a consensus price target of $83.63.
Shares of NYSE:NUS opened at $67.31 on Friday. Nu Skin Enterprises has a 1 year low of $56.09 and a 1 year high of $88.68. The company has a market cap of $3.73 billion, a PE ratio of 20.84, a price-to-earnings-growth ratio of 1.53 and a beta of 0.69. The company has a debt-to-equity ratio of 0.44, a quick ratio of 1.25 and a current ratio of 1.93.
In other Nu Skin Enterprises news, General Counsel D Matthew Dorny sold 1,250 shares of the firm’s stock in a transaction on Wednesday, January 2nd. The stock was sold at an average price of $60.60, for a total value of $75,750.00. Following the transaction, the general counsel now owns 32,621 shares in the company, valued at approximately $1,976,832.60. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 3.00% of the company’s stock.
Hedge funds have recently made changes to their positions in the business. Deutsche Bank AG lifted its holdings in Nu Skin Enterprises by 7.6% in the 3rd quarter. Deutsche Bank AG now owns 424,947 shares of the company’s stock valued at $35,021,000 after purchasing an additional 29,919 shares in the last quarter. Retirement Systems of Alabama lifted its holdings in Nu Skin Enterprises by 0.4% in the 4th quarter. Retirement Systems of Alabama now owns 72,023 shares of the company’s stock valued at $4,417,000 after purchasing an additional 260 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. purchased a new position in Nu Skin Enterprises in the 3rd quarter valued at $224,000. GSA Capital Partners LLP lifted its holdings in Nu Skin Enterprises by 3.5% in the 3rd quarter. GSA Capital Partners LLP now owns 46,997 shares of the company’s stock valued at $3,873,000 after purchasing an additional 1,591 shares in the last quarter. Finally, Seven Eight Capital LP purchased a new position in shares of Nu Skin Enterprises during the 3rd quarter worth $1,698,000. Institutional investors own 76.69% of the company’s stock.
Nu Skin Enterprises Company Profile
Nu Skin Enterprises, Inc develops and distributes anti-aging personal care products and nutritional supplements under the Nu Skin and Pharmanex category brands worldwide. It provides skin care systems and targeted treatment products, including ageLOC Me customized skin care systems, ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products, as well as a range of other cosmetic, personal care, and hair care products.
Featured Article: Intrinsic Value
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.